HER2/neu may not be an interesting target in biliary cancers: Results of an early phase II Study with Lapatinib

Joshua Peck, Lai Wei, Mark Zalupski, Bert O'Neil, Miguel Villalona Calero, Tanios Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'HER2/neu may not be an interesting target in biliary cancers: Results of an early phase II Study with Lapatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences